AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dare Bioscience, Inc. Director's Dealing 2016

Jan 7, 2016

34825_dirs_2016-01-07_fa04a21e-7b2e-4b89-b2fd-d487c916d20d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-12-31

Reporting Person: GUIFFRE CHRISTOPHERD T (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-31	Common Stock	A	2757	$2.38	Acquired	2757	Direct

Footnotes

F1: These shares were acquired under the Cerulean Pharma Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule
16b-3(d) and Rule 16b-3(c)